Nöromyelitis Optika ve Multipl Sklerozlu Bireylerde İlk Demiyelinizan Atakta İnflamatuar Belirteçlerin Karşılaştırılması

Year 2023, Volume: 6 Issue: 3, 472 - 476, 21.10.2023

Sena Destan Bünül , Beyza Canik , Hüsnü Efendi

https://doi.org/10.53446/actamednicomedia.1370406

Abstract

Amaç:
Bu çalışmanın amacı, nöromyelitis spektrum hastalıkları (NMOSD) ve multipl skleroz (MS) hastalarında ilk akut atak döneminde periferik kan enflamasyon belirteçlerini değerlendirmek ve bu belirteçlerin hastalıklar arasındaki farklılıkları ortaya koymaktır.
Yöntem:
Çalışmaya Kocaeli Üniversitesi Tıp Fakültesi Nöroloji anabilim dalı MS polikliniği tarafından izlenen hastalara ait veriler retrospektif olarak dahil edildi. NMOSD ve MS tanıları 2015 ve 2017 kriterlerine göre konuldu. İlk akut atak döneminde, NLR, PLR, MLR, SII, AISI ve SIRI gibi enflamatuvar parametreler, periferik kan örneklerinden hesaplandı. Hastaların demografik özellikleri ve EDSS skorları kayıt programından alındı.
Bulgular:
Toplam 44 hasta çalışmaya dahil edildi. NMO tanılı hastaların NLR, PLR, SII ve SIRI değerleri, MS hastalarına göre anlamlı derecede yüksekti. Bu sonuçlar, NMOSD ve MS'nin immunpatogenezindeki farklılıkları yansıtabilir.
Sonuç:
NLR, PLR, SII ve SIRI gibi enflamatuvar belirteçlerin NMOSD ve MS ayırıcı tanısında kullanılabileceği ve hastalığın başlangıç dönemindeki enflamatuvar aktiviteyi değerlendirmede önemli bir rol oynayabileceği düşünülmektedir. Bu bulgular, daha büyük ve çok merkezli çalışmalarla doğrulanmalıdır.

Keywords

multipl skleroz, nöromiyelitis optika, inflamasyon, nörodejenerasyon, demiyelinizasyon

Ethical Statement

Çalışmamız Kocaeli Üniversitesi Girişimsel Olmayan Etik Kurul tarafından GOKAEK-2023/14.38 koduyla uygun bulunmuştur.

Supporting Institution

yoktur

References

• Peterson LK, Fujinami RS. Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007;184(1-2):37-44. doi:10.1016/j.jneuroim.2006.11.015
• Dos Passos GR, Sato DK, Becker J, Fujihara K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic ımplications. Mediators Inflamm. 2016;2016:5314541. doi:10.1155/2016/5314541
• Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545-558. doi:10.1038/nri3871
• Cree B. Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep. 2008;8(5):427-433. doi:10.1007/s11910-008-0066-2
• Gokce SF, Bolayır A, Cigdem B, Yildiz B. The role of systemic immune inflammatory ındex in showing active lesion ın patients with multiple sclerosis: SII and other inflamatuar biomarker in radiological active multiple sclerosis patients. BMC Neurol. 2023;23(1):64. doi:10.1186/s12883-023-03101-0
• Fest J, Ruiter R, Ikram MA, Voortman T, van Eijck CHJ, Stricker BH. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study: a population-based prospective cohort study. Sci Rep. 2018;8(1):10566. doi:10.1038/s41598-018-28646-w
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173. doi:10.1016/S1474-4422(17)30470-2
• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-189. doi:10.1212/WNL.0000000000001729
• Woodberry T, Bouffler SE, Wilson AS, Buckland RL, Brüstle A. The emerging role of neutrophil granulocytes in multiple sclerosis. J Clin Med. 2018;7(12):511. doi:10.3390/jcm7120511
• D'Amico E, Zanghì A, Romano A, Sciandra M, Palumbo GAM, Patti F. The Neutrophil-to-lymphocyte ratio is related to disease activity in relapsing remitting multiple sclerosis. Cells. 2019;8(10):1114. doi:10.3390/cells8101114
• Guzel I, Mungan S, Oztekin ZN, Ak F. Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis? J Chin Med Assoc. 2016;79(2):54-57. doi:10.1016/j.jcma.2015.08.010
• Hasselbalch IC, Søndergaard HB, Koch-Henriksen N, et al. The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis. Mult Scler J Exp Transl Clin. 2018;4(4):2055217318813183. doi:10.1177/2055217318813183
• Miller JM, Beales JT, Montierth MD, Briggs FB, Frodsham SF, Davis MF. The Impact of multiple sclerosis disease status and subtype on hematological profile. Int J Environ Res Public Health. 2021;18(6):3318. doi:10.3390/ijerph18063318
• Zhou Y, Xie H, Zhao Y, et al. Neutrophil-to-lymphocyte ratio on admission is an independent risk factor for the severity of neurological impairment at disease onset in patients with a first episode of neuromyelitis optica spectrum disorder. Neuropsychiatr Dis Treat. 2021;17:1493-1503. doi:10.2147/NDT.S311942
• Lin J, Xue B, Li J, et al. Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSH. Neurol Sci. 2017;38(10):1859-1863. doi:10.1007/s10072-017-3068-5
• Carnero Contentti E, Delgado-García G, Criniti J, et al. An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-Positive NMOSH. Front Immunol. 2021;12:628024. doi:10.3389/fimmu.2021.628024
• Ma L, Zeng A, Chen B, Chen Y, Zhou R. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: A meta-analysis. Int Immunopharmacol. 2019;76:105949. doi:10.1016/j.intimp.2019.105949
• Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The Platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345-357. doi:10.3343/alm.2019.39.4.345
• Lee YH, Song GG. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behçet's disease and their correlation with disease activity: A meta-analysis. Int J Rheum Dis. 2018;21(12):2180-2187. doi:10.1111/1756-185X.13404
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
• Yan SL, Russell J, Granger DN. Platelet activation and platelet-leukocyte aggregation elicited in experimental colitis are mediated by interleukin-6. Inflamm Bowel Dis. 2014;20(2):353-362. doi:10.1097/01.MIB.0000440614.83703.84
• Güçlü M, Ağan AF. Relationship of peripheral blood neutrophil to lymphocyte ratio and irritable bowel syndrome. Turk J Med Sci. 2017;47(4):1067-1071. doi:10.3906/sag-1509-44
• Yıldız G, Selvi F, Bedel C, Zortuk Ö, Yavuz YF. Systemic inflammatory response index (Siri) and systemic immune-inflammation index (SII) to show thrombus localization in patients with acute pulmonary embolism. Osmangazi Journal of Medicine. doi:10.20515/otd.1276480
• Song Y, Luo Y, Zhang F, et al. Systemic immune-inflammation index predicts postoperative delirium in elderly patients after surgery: a retrospective cohort study. BMC Geriatr. 2022;22(1):730. doi:10.1186/s12877-022-03418-4